CMO & CDMO Biotechnology Market

The rising demand for pharmaceuticals and other major driving factors is expected to favor the rise in the global CMO & CDMO Biotechnology market


Reports and Insights has published a new report titled, “CMO & CDMO Biotechnology Market: Opportunity Analysis and Future Assessment 2022-2030

The global CMO & CDMO biotechnology market is expected to reach at a value of US$ 27.5 Bn by 2030 end at a CAGR of 10.8%

Global CMO & CDMO Biotechnology Market, By CDMO Type (Whole Drug Development and Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing (Injectable)), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, CVS, Metabolic Disorders/Endocrinology, Other Therapeutic Areas), By Product (Monoclonal Antibodies, Antibody Fragments, Recombinant Proteins, Vaccines, Biosimilars, Therapeutic Proteins, Others), By Molecule Type (Viral Vector Manufacturing, Cell and Gene Therapies (CGT), API manufacturing (Small molecule API manufacturers, Biologics API Manufacturing, Injectable manufacturing), By Application (Preclinical CMO/CDMO, Clinical CMO/CDMO, Commercial CMO/CDMO, Others), By Platform/ Expression System (Mammalian, Microbial (Bacteria, Yeast), Insect, Others), By End User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Academic Institutes and Research Centers) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2022 and 2030.

The Contract Manufacturing Organization (CMO) and a Contract Development and Manufacturing Organization (CDMO) can be comprehended as the associations that provide development and manufacturing services to biotechnology/biopharmaceuticals companies on a contract basis to offer an extensive range of services, scaling from drug development through drug manufacturing.

Basically, pharma/biopharma and biotechnology companies’ associates with CDMOs as a means to outsource drug development and drug manufacturing. In the past few years, the contract research organization (CRO) and pharmaceutical contract development and manufacturing organization (CDMO) industries are witnessing a major breakthrough with regard to the significance and value of merger and acquisition (M&A) deals. Attributing to which, the global CMO & CDMO biotechnology market is projected to rise significantly over the years.

In addition to that, the higher use of pharmaceuticals, downsizing of supply chains to regional and national manufacturing centers, and emergence of novel advanced medicines urging robust investor interest in these business domains, are some other major factors that are projected to offer huge breakthroughs to the growth of the global CMO & CDMO biotechnology market in the forthcoming years.

Reports and Insights Study identifies some of the key participating players in the CMO & CDMO Biotechnology market globally are Boehringer Ingelheim Group, Wuxi Biologics, Samsung Biologics, Lonza Group, Fujifilm Diosynth Biotechnologies USA Inc., Toyobo Co. Limited, Parexel International Corporation, Icon PLC, Binex Co. Limited, JRS Pharma, Rentschler Biotechnologies, AGC Biologics, Sandoz Biopharmaceuticals (Novartis AG), Catalent Inc., AbbVie Contract Manufacturing, among others.

About Reports and Insights

Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us

Reports and Insights

Tel: +1-(718)-312-8686

For Sales Query: [email protected]

For New Topics & Other Info: [email protected]

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy